Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Guido Tricot

Concepts (537)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
135
2022
2686
10.150
 Why?
Hematopoietic Stem Cell Transplantation
25
2022
531
3.930
 Why?
Pyrazines
19
2014
205
2.990
 Why?
Boronic Acids
19
2014
201
2.990
 Why?
Antineoplastic Combined Chemotherapy Protocols
33
2019
1008
2.770
 Why?
Thalidomide
27
2012
405
2.680
 Why?
Antineoplastic Agents
30
2020
1244
2.280
 Why?
Transplantation, Autologous
27
2022
459
2.100
 Why?
Drug Resistance, Neoplasm
17
2020
297
1.810
 Why?
Transplantation Conditioning
9
2019
89
1.800
 Why?
Paraproteinemias
8
2018
66
1.590
 Why?
Neoplastic Stem Cells
5
2020
102
1.440
 Why?
Protease Inhibitors
6
2011
63
1.320
 Why?
Humans
146
2022
50276
1.260
 Why?
Venous Thrombosis
7
2009
104
1.250
 Why?
Angiogenesis Inhibitors
9
2009
211
1.180
 Why?
Hematopoietic Stem Cell Mobilization
5
2014
65
1.150
 Why?
Stem Cell Transplantation
12
2011
195
1.150
 Why?
Gene Expression Regulation, Neoplastic
13
2020
878
1.090
 Why?
Prognosis
32
2021
2057
1.050
 Why?
Busulfan
3
2019
18
1.040
 Why?
Alkaline Phosphatase
5
2011
100
1.040
 Why?
Aged
56
2021
10017
0.990
 Why?
Middle Aged
58
2021
13149
0.980
 Why?
Melphalan
15
2019
176
0.980
 Why?
Treatment Outcome
39
2022
5421
0.910
 Why?
Plasma Cells
10
2016
225
0.880
 Why?
Chromosome Aberrations
9
2008
302
0.800
 Why?
Thromboembolism
3
2009
58
0.800
 Why?
Male
66
2021
27231
0.770
 Why?
Chromosomes, Human, Pair 13
6
2008
47
0.740
 Why?
Neoplasm Proteins
6
2021
379
0.740
 Why?
Female
62
2021
27910
0.720
 Why?
Immunoglobulin Light Chains
3
2016
97
0.700
 Why?
Disease-Free Survival
14
2019
520
0.690
 Why?
Blood Transfusion
1
2018
123
0.680
 Why?
Bone Remodeling
2
2010
178
0.670
 Why?
Survival Rate
18
2019
995
0.670
 Why?
Anticoagulants
5
2009
263
0.670
 Why?
Immunologic Factors
5
2012
123
0.660
 Why?
Dexamethasone
14
2009
398
0.640
 Why?
Receptors, Retinoic Acid
2
2013
28
0.630
 Why?
Antineoplastic Agents, Alkylating
7
2008
77
0.620
 Why?
IMP Dehydrogenase
2
2006
5
0.620
 Why?
Mycophenolic Acid
2
2006
17
0.610
 Why?
Proteasome Inhibitors
6
2018
105
0.610
 Why?
Gene Expression Profiling
17
2018
1082
0.600
 Why?
Cell Line, Tumor
17
2020
1472
0.580
 Why?
Combined Modality Therapy
13
2008
701
0.570
 Why?
Recurrence
16
2018
688
0.570
 Why?
Follow-Up Studies
20
2018
2357
0.560
 Why?
Antigens, Neoplasm
5
2007
167
0.560
 Why?
Adult
37
2018
13861
0.550
 Why?
Venous Thromboembolism
3
2011
58
0.550
 Why?
Cell Proliferation
15
2020
1117
0.540
 Why?
Up-Regulation
5
2020
519
0.540
 Why?
Osteogenesis
3
2012
387
0.520
 Why?
Antibodies, Monoclonal
3
2015
534
0.520
 Why?
Disease Progression
12
2019
867
0.520
 Why?
Apoptosis
9
2019
1313
0.520
 Why?
Doxorubicin
8
2018
264
0.510
 Why?
Survival Analysis
12
2021
787
0.510
 Why?
Central Nervous System Neoplasms
2
2004
50
0.510
 Why?
Bone Diseases
3
2012
105
0.500
 Why?
Retrospective Studies
16
2018
5676
0.490
 Why?
Signal Transduction
12
2020
1801
0.490
 Why?
Thrombosis
4
2012
255
0.480
 Why?
Myeloablative Agonists
5
2014
36
0.480
 Why?
Transplantation, Homologous
6
2004
165
0.460
 Why?
Oligopeptides
2
2013
98
0.460
 Why?
Bone Marrow
7
2022
408
0.460
 Why?
Animals
28
2021
14247
0.450
 Why?
Meta-Analysis as Topic
2
2015
38
0.440
 Why?
Osteoblasts
4
2007
539
0.440
 Why?
Salvage Therapy
9
2012
140
0.440
 Why?
Granulocyte Colony-Stimulating Factor
2
2008
65
0.440
 Why?
Hematopoietic Stem Cells
2
2010
232
0.430
 Why?
Risk Factors
18
2018
3860
0.430
 Why?
Bone Marrow Transplantation
5
2007
165
0.420
 Why?
Ultrasonography, Doppler
2
2007
58
0.410
 Why?
Remission Induction
10
2008
217
0.410
 Why?
Enzyme Inhibitors
2
2019
439
0.400
 Why?
Membrane Proteins
4
2017
376
0.400
 Why?
Prospective Studies
9
2019
2349
0.400
 Why?
Myelodysplastic Syndromes
4
2007
83
0.400
 Why?
Neoplasm, Residual
4
2022
172
0.400
 Why?
Clinical Trials as Topic
8
2007
483
0.390
 Why?
Cell Cycle Proteins
2
2021
193
0.390
 Why?
B-Lymphocytes
4
2021
183
0.390
 Why?
Waldenstrom Macroglobulinemia
3
2018
34
0.390
 Why?
Lymphoma, B-Cell
3
2021
60
0.380
 Why?
Immunosuppressive Agents
3
2005
251
0.370
 Why?
Neovascularization, Pathologic
1
2009
172
0.370
 Why?
Bone Neoplasms
1
2010
194
0.360
 Why?
Brain Diseases, Metabolic
1
2007
7
0.350
 Why?
Hyperammonemia
1
2007
17
0.350
 Why?
Proteasome Endopeptidase Complex
4
2018
133
0.340
 Why?
Chromosome Deletion
3
2008
146
0.340
 Why?
Mice
17
2021
6232
0.340
 Why?
Farnesyltranstransferase
1
2006
3
0.340
 Why?
Thrombophilia
4
2009
23
0.340
 Why?
Amyloidosis
2
2007
81
0.340
 Why?
Research Design
1
2009
342
0.340
 Why?
Peripheral Blood Stem Cell Transplantation
4
2014
58
0.330
 Why?
Small Molecule Libraries
2
2019
73
0.330
 Why?
Hemostasis
1
2007
65
0.330
 Why?
Dose-Response Relationship, Drug
6
2016
1550
0.320
 Why?
Sirolimus
1
2006
62
0.320
 Why?
Aged, 80 and over
11
2019
3496
0.320
 Why?
Gastrointestinal Neoplasms
1
2006
37
0.320
 Why?
Bone and Bones
1
2010
512
0.320
 Why?
In Situ Hybridization, Fluorescence
6
2016
273
0.300
 Why?
Cell Survival
8
2018
680
0.300
 Why?
Diploidy
2
2004
31
0.300
 Why?
beta 2-Microglobulin
5
2008
40
0.300
 Why?
Caspases
1
2006
154
0.300
 Why?
Antibody Formation
1
2005
65
0.290
 Why?
Activated Protein C Resistance
4
2011
11
0.290
 Why?
Killer Cells, Natural
3
2012
106
0.290
 Why?
Religion
1
2005
70
0.290
 Why?
Aneuploidy
1
2004
21
0.290
 Why?
Flow Cytometry
6
2018
581
0.290
 Why?
Enoxaparin
1
2004
24
0.290
 Why?
Case-Control Studies
10
2018
1224
0.280
 Why?
Immunotherapy, Adoptive
3
2012
76
0.270
 Why?
Ubiquitination
2
2021
49
0.270
 Why?
Adaptation, Psychological
1
2005
223
0.270
 Why?
Attitude to Health
1
2005
231
0.260
 Why?
Randomized Controlled Trials as Topic
4
2012
506
0.260
 Why?
Cell Communication
2
2006
72
0.260
 Why?
Pyrimidines
3
2015
188
0.250
 Why?
T-Lymphocytes
6
2018
331
0.250
 Why?
Cancer Vaccines
3
2010
102
0.250
 Why?
Multivariate Analysis
5
2008
678
0.250
 Why?
Mice, Inbred NOD
6
2020
99
0.250
 Why?
Antigens, CD34
1
2003
83
0.250
 Why?
Blood Coagulation
1
2003
78
0.250
 Why?
Cytogenetic Analysis
6
2007
78
0.250
 Why?
Cisplatin
6
2009
342
0.250
 Why?
Graft vs Host Disease
5
2010
83
0.250
 Why?
STAT3 Transcription Factor
4
2015
84
0.240
 Why?
Leukemia, Myeloid
1
2002
58
0.240
 Why?
Cyclophosphamide
4
2003
190
0.240
 Why?
Critical Illness
1
2005
315
0.240
 Why?
Chromosome Disorders
1
2002
39
0.240
 Why?
Etoposide
5
2009
90
0.230
 Why?
Neoplasms, Second Primary
1
2002
72
0.230
 Why?
Hypothyroidism
1
2002
49
0.230
 Why?
Parathyroid Hormone
3
2010
220
0.230
 Why?
Kidney
1
2007
754
0.230
 Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
100
0.230
 Why?
Chromosomes, Human, Pair 1
3
2006
99
0.220
 Why?
Logistic Models
5
2018
1001
0.220
 Why?
Neoplasms
2
2009
1143
0.210
 Why?
Cytotoxicity, Immunologic
3
2012
62
0.210
 Why?
Time Factors
9
2016
3352
0.210
 Why?
Xenograft Model Antitumor Assays
5
2019
206
0.210
 Why?
Glucuronidase
2
2018
50
0.200
 Why?
Hematologic Neoplasms
2
2016
88
0.200
 Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
141
0.200
 Why?
DNA-Binding Proteins
2
2020
493
0.190
 Why?
Syndecan-1
3
2017
82
0.190
 Why?
Predictive Value of Tests
5
2009
1044
0.190
 Why?
Hydrocarbons, Aromatic
1
2018
3
0.190
 Why?
Drug Tolerance
1
2018
61
0.190
 Why?
Jehovah's Witnesses
1
2018
7
0.190
 Why?
Solvents
1
2018
39
0.190
 Why?
Kaplan-Meier Estimate
6
2015
529
0.190
 Why?
Pyridines
1
2019
138
0.190
 Why?
T-Lymphocytes, Cytotoxic
3
2010
76
0.190
 Why?
Vincristine
3
2003
94
0.180
 Why?
Cytokines
4
2007
671
0.180
 Why?
Dendritic Cells
3
2010
148
0.180
 Why?
CDC2-CDC28 Kinases
2
2015
14
0.180
 Why?
Platelet Count
3
2008
77
0.180
 Why?
Iron
2
2017
144
0.170
 Why?
Arsenicals
2
2010
14
0.170
 Why?
Pyruvate Kinase
1
2017
8
0.170
 Why?
Drug Combinations
1
2017
128
0.170
 Why?
Oxides
2
2010
20
0.170
 Why?
Occupational Diseases
1
2018
98
0.170
 Why?
Ascorbic Acid
1
2017
34
0.170
 Why?
Mice, SCID
5
2018
199
0.170
 Why?
RNA Splicing
1
2017
34
0.170
 Why?
Interleukin-6
2
2018
299
0.170
 Why?
Anthropometry
1
2017
96
0.170
 Why?
Occupational Exposure
1
2018
137
0.160
 Why?
Glycolysis
1
2017
64
0.160
 Why?
Neoplasm Recurrence, Local
3
2022
576
0.160
 Why?
Factor V
3
2011
13
0.160
 Why?
Immunoglobulin lambda-Chains
1
2016
16
0.160
 Why?
Immunoglobulin kappa-Chains
1
2016
31
0.160
 Why?
Oncolytic Virotherapy
1
2015
12
0.160
 Why?
Reproductive History
1
2015
4
0.160
 Why?
Immunotherapy
4
2006
241
0.160
 Why?
Tumor Cells, Cultured
6
2019
508
0.160
 Why?
Leukocytes, Mononuclear
2
2014
124
0.160
 Why?
Incidence
3
2009
1051
0.160
 Why?
Hormone Replacement Therapy
1
2015
21
0.160
 Why?
Fibrinolytic Agents
2
2007
138
0.160
 Why?
Transcription Factors
1
2020
618
0.150
 Why?
MicroRNAs
1
2020
358
0.150
 Why?
Cyclopentanes
1
2015
16
0.150
 Why?
Cell Adhesion Molecules
1
2015
96
0.150
 Why?
Ubiquitins
1
2015
39
0.150
 Why?
Hemorrhage
2
2007
190
0.150
 Why?
Cation Transport Proteins
1
2015
27
0.150
 Why?
Aldehyde Dehydrogenase
1
2014
28
0.150
 Why?
Postmenopause
1
2015
83
0.150
 Why?
Receptors, Cell Surface
1
2015
137
0.140
 Why?
Leukapheresis
1
2014
15
0.140
 Why?
Drug Monitoring
1
2015
90
0.140
 Why?
Transplantation Chimera
3
2003
17
0.140
 Why?
NF-kappa B
3
2018
335
0.140
 Why?
Osteoclasts
3
2015
443
0.140
 Why?
Protein-Tyrosine Kinases
1
2015
103
0.140
 Why?
Myeloma Proteins
2
2020
29
0.140
 Why?
Translocation, Genetic
3
2005
278
0.140
 Why?
Intestines
1
2016
207
0.140
 Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
32
0.140
 Why?
Veratrum Alkaloids
1
2013
4
0.140
 Why?
Gene Deletion
3
2004
278
0.130
 Why?
Isoxazoles
1
2013
14
0.130
 Why?
Multidrug Resistance-Associated Proteins
1
2013
16
0.130
 Why?
Body Mass Index
1
2017
676
0.130
 Why?
Sulfones
1
2013
22
0.130
 Why?
Hedgehog Proteins
1
2013
34
0.130
 Why?
Itraconazole
1
2013
41
0.130
 Why?
Metaphase
3
2008
57
0.130
 Why?
Tumor Microenvironment
1
2014
137
0.130
 Why?
Intercellular Adhesion Molecule-1
1
2013
75
0.130
 Why?
Polymorphism, Single Nucleotide
1
2016
544
0.130
 Why?
Biopsy
2
2006
686
0.130
 Why?
Wnt Proteins
1
2013
109
0.130
 Why?
Carrier Proteins
2
2017
358
0.130
 Why?
Genetic Predisposition to Disease
1
2016
564
0.120
 Why?
Cell Differentiation
3
2018
750
0.120
 Why?
Renal Insufficiency
3
2009
134
0.120
 Why?
Viremia
1
2012
22
0.120
 Why?
Infusions, Intravenous
2
2003
243
0.120
 Why?
Risk
2
2011
342
0.120
 Why?
Chromosomes, Human, Pair 11
2
2002
61
0.120
 Why?
Risk Assessment
4
2016
1387
0.120
 Why?
Clinical Trials, Phase III as Topic
1
2012
45
0.120
 Why?
Cytomegalovirus Infections
1
2012
45
0.120
 Why?
Clinical Trials, Phase II as Topic
1
2012
52
0.120
 Why?
Drug Delivery Systems
2
2005
152
0.120
 Why?
Receptors, KIR
2
2008
16
0.120
 Why?
Fluorodeoxyglucose F18
2
2021
199
0.120
 Why?
Reoperation
2
2004
443
0.120
 Why?
Medical Oncology
1
2012
89
0.120
 Why?
Ligands
2
2009
248
0.110
 Why?
Radiopharmaceuticals
2
2021
252
0.110
 Why?
Phosphorylation
2
2020
620
0.110
 Why?
Drug Evaluation, Preclinical
1
2012
157
0.110
 Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
5
0.110
 Why?
Tretinoin
2
2009
63
0.110
 Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
22
0.110
 Why?
Alcohol Drinking
1
2013
261
0.110
 Why?
Inflammation
1
2016
635
0.110
 Why?
Antineoplastic Agents, Hormonal
2
2007
54
0.110
 Why?
Monoclonal Gammopathy of Undetermined Significance
2
2011
77
0.110
 Why?
Age Factors
3
2005
1226
0.110
 Why?
Janus Kinase 1
1
2010
21
0.110
 Why?
Cyclin-Dependent Kinases
1
2010
31
0.110
 Why?
MAP Kinase Kinase 1
1
2010
27
0.110
 Why?
Recombinant Proteins
2
2010
583
0.100
 Why?
Authorship
1
2010
14
0.100
 Why?
Smoking
1
2014
554
0.100
 Why?
Conflict of Interest
1
2010
22
0.100
 Why?
Drug Industry
1
2010
40
0.100
 Why?
Macrophages
1
2013
390
0.100
 Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
110
0.100
 Why?
Down-Regulation
2
2010
396
0.100
 Why?
Bone Density Conservation Agents
1
2010
82
0.100
 Why?
Neoplasm Staging
3
2015
792
0.100
 Why?
Disclosure
1
2010
42
0.100
 Why?
Chromosome Banding
2
2006
27
0.100
 Why?
Diphosphonates
1
2010
97
0.100
 Why?
Leukocyte Count
2
2014
82
0.100
 Why?
Plasmacytoma
2
2011
43
0.100
 Why?
Maximum Tolerated Dose
2
2009
38
0.100
 Why?
Periodicals as Topic
1
2010
65
0.100
 Why?
Cryoglobulinemia
1
2008
12
0.100
 Why?
Cell Cycle
2
2010
270
0.090
 Why?
Mice, Transgenic
3
2021
724
0.090
 Why?
Oligonucleotide Array Sequence Analysis
5
2014
477
0.090
 Why?
Cytogenetics
1
2008
27
0.090
 Why?
Prednisone
2
2009
115
0.090
 Why?
Blotting, Western
3
2015
704
0.090
 Why?
Pulmonary Embolism
1
2009
93
0.090
 Why?
Hemoglobins
1
2008
113
0.090
 Why?
Vascular Endothelial Growth Factor A
1
2009
220
0.090
 Why?
Magnetic Resonance Imaging
3
2007
1592
0.090
 Why?
Neutrophils
2
2014
161
0.090
 Why?
Adoptive Transfer
1
2007
39
0.090
 Why?
Sulfonamides
1
2009
141
0.090
 Why?
Polyethylene Glycols
1
2008
94
0.090
 Why?
Heparin, Low-Molecular-Weight
1
2007
22
0.090
 Why?
Immunophenotyping
2
2007
128
0.090
 Why?
Histocompatibility Antigens Class I
1
2007
44
0.090
 Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
699
0.090
 Why?
Phlebography
1
2007
72
0.090
 Why?
Fibrinolysis
1
2007
11
0.090
 Why?
Ammonia
1
2007
71
0.090
 Why?
Blood Coagulation Factors
1
2007
18
0.090
 Why?
Serum Albumin
2
2008
65
0.080
 Why?
Chi-Square Distribution
1
2007
328
0.080
 Why?
Biomedical Research
1
2010
230
0.080
 Why?
Osteoprotegerin
1
2006
53
0.080
 Why?
Guanosine
1
2006
6
0.080
 Why?
Drug Administration Schedule
2
2006
420
0.080
 Why?
Cell Membrane
1
2007
271
0.080
 Why?
Models, Genetic
1
2006
195
0.080
 Why?
Antibiotics, Antineoplastic
1
2006
85
0.080
 Why?
Femur Head Necrosis
1
2005
16
0.080
 Why?
Brain
2
2007
1378
0.080
 Why?
Survivors
1
2006
104
0.080
 Why?
Neovascularization, Physiologic
1
2005
73
0.070
 Why?
Guanosine Triphosphate
1
2004
21
0.070
 Why?
Kidney Transplantation
1
2007
161
0.070
 Why?
Sex Factors
3
2016
781
0.070
 Why?
Renal Dialysis
1
2007
174
0.070
 Why?
Gene Duplication
1
2005
16
0.070
 Why?
Karyotyping
1
2005
99
0.070
 Why?
Tissue Donors
2
2003
97
0.070
 Why?
Oncogene Proteins, Fusion
1
2005
62
0.070
 Why?
Thrombophlebitis
1
2004
30
0.070
 Why?
Proteolysis
2
2015
96
0.070
 Why?
Genomic Instability
1
2005
93
0.070
 Why?
Tomography, Emission-Computed
1
2004
70
0.070
 Why?
Antibodies
1
2005
172
0.070
 Why?
RNA Interference
2
2015
201
0.070
 Why?
Anxiety
1
2005
252
0.070
 Why?
Discitis
1
2003
8
0.070
 Why?
Stem Cell Factor
1
2003
8
0.070
 Why?
Lymphocyte Transfusion
1
2003
13
0.060
 Why?
Confidence Intervals
1
2003
178
0.060
 Why?
Probability
1
2003
185
0.060
 Why?
Chromatography, High Pressure Liquid
1
2004
440
0.060
 Why?
Interferons
1
2002
36
0.060
 Why?
Patient Selection
1
2005
292
0.060
 Why?
Neoplastic Cells, Circulating
1
2004
93
0.060
 Why?
Cyclosporine
1
2003
67
0.060
 Why?
Tacrolimus
1
2003
39
0.060
 Why?
Cell Count
1
2003
192
0.060
 Why?
Thyroid Function Tests
1
2002
27
0.060
 Why?
Blood Group Incompatibility
1
2002
4
0.060
 Why?
Drug Therapy, Combination
2
2017
423
0.060
 Why?
ABO Blood-Group System
1
2002
14
0.060
 Why?
Thyrotropin
1
2002
42
0.060
 Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.060
 Why?
Administration, Oral
1
2003
459
0.060
 Why?
Stromal Cells
1
2002
98
0.060
 Why?
Drug Interactions
1
2002
215
0.060
 Why?
Fatal Outcome
1
2002
231
0.060
 Why?
Chromosome Mapping
3
2006
165
0.060
 Why?
Graft Survival
1
2002
163
0.060
 Why?
Cell Division
1
2002
366
0.060
 Why?
Acute Disease
1
2002
411
0.060
 Why?
Cluster Analysis
3
2006
249
0.050
 Why?
Neoplasm Transplantation
1
2020
92
0.050
 Why?
Cells, Cultured
1
2005
1787
0.050
 Why?
Young Adult
3
2015
4120
0.050
 Why?
3' Untranslated Regions
1
2020
55
0.050
 Why?
Depression
1
2005
559
0.050
 Why?
Tomography, X-Ray Computed
1
2006
1235
0.050
 Why?
Odds Ratio
2
2016
606
0.050
 Why?
Pain
1
2003
362
0.050
 Why?
Positron-Emission Tomography
1
2021
311
0.050
 Why?
Crystallography, X-Ray
1
2019
160
0.050
 Why?
Postoperative Complications
1
2007
1005
0.050
 Why?
Staphylococcal Infections
1
2003
291
0.050
 Why?
Mice, Nude
1
2019
270
0.050
 Why?
Protein Conformation
1
2019
214
0.050
 Why?
Antigens, CD
2
2015
264
0.050
 Why?
Coculture Techniques
2
2012
161
0.050
 Why?
Antigens, CD19
1
2018
22
0.050
 Why?
Receptors, Interleukin-6
1
2018
31
0.050
 Why?
Mice, Inbred BALB C
1
2019
370
0.050
 Why?
Bone Marrow Cells
2
2015
250
0.050
 Why?
Microarray Analysis
1
2018
83
0.050
 Why?
Drug Resistance
1
2018
80
0.050
 Why?
Protein Stability
1
2018
47
0.050
 Why?
Interferon-gamma
2
2010
194
0.050
 Why?
Gene Knockdown Techniques
1
2018
128
0.050
 Why?
Disease Management
1
2020
198
0.050
 Why?
Vaccination
2
2010
156
0.040
 Why?
Epidemiologic Methods
2
2008
50
0.040
 Why?
Aerobiosis
1
2017
15
0.040
 Why?
HLA-A Antigens
2
2007
14
0.040
 Why?
Transplantation, Heterologous
1
2017
80
0.040
 Why?
Microfilament Proteins
1
2017
52
0.040
 Why?
Thyroid Hormones
1
2017
21
0.040
 Why?
Calcium-Binding Proteins
1
2017
59
0.040
 Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
3
0.040
 Why?
Polycomb Repressive Complex 1
1
2016
5
0.040
 Why?
Proto-Oncogene Proteins c-myc
1
2017
56
0.040
 Why?
Genetic Loci
1
2016
62
0.040
 Why?
Mice, Inbred ICR
1
2016
27
0.040
 Why?
Antibodies, Neoplasm
2
2006
38
0.040
 Why?
Microscopy, Electron, Transmission
1
2015
86
0.040
 Why?
Protein Binding
1
2018
756
0.040
 Why?
Reoviridae
1
2015
28
0.040
 Why?
ras Proteins
1
2015
69
0.040
 Why?
Tumor Burden
1
2016
142
0.040
 Why?
Genome-Wide Association Study
1
2016
191
0.040
 Why?
Receptors, Transferrin
1
2015
12
0.040
 Why?
Mice, Knockout
1
2018
980
0.040
 Why?
Side-Population Cells
1
2015
2
0.040
 Why?
Retinal Dehydrogenase
1
2014
9
0.040
 Why?
Lentivirus
1
2015
17
0.040
 Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.040
 Why?
Cyclin B
1
2014
6
0.040
 Why?
Adenine
1
2015
44
0.040
 Why?
Portraits as Topic
1
2014
2
0.040
 Why?
CDC2 Protein Kinase
1
2014
23
0.040
 Why?
Repressor Proteins
1
2016
170
0.040
 Why?
Molecular Targeted Therapy
1
2016
134
0.040
 Why?
Family
1
2016
184
0.040
 Why?
Cell Lineage
1
2014
99
0.040
 Why?
RNA, Messenger
2
2010
1239
0.040
 Why?
Drug Synergism
1
2014
168
0.030
 Why?
Piperidines
1
2015
102
0.030
 Why?
beta Catenin
1
2015
98
0.030
 Why?
Reactive Oxygen Species
1
2017
504
0.030
 Why?
Mitosis
1
2014
103
0.030
 Why?
Disease Models, Animal
2
2013
1638
0.030
 Why?
Drug Screening Assays, Antitumor
1
2014
144
0.030
 Why?
Pyrazoles
1
2015
118
0.030
 Why?
Models, Biological
1
2018
842
0.030
 Why?
Peptide Library
1
2013
27
0.030
 Why?
Proportional Hazards Models
2
2006
450
0.030
 Why?
Receptors, IgG
1
2013
23
0.030
 Why?
Cell Movement
1
2015
300
0.030
 Why?
Patient Safety
1
2014
124
0.030
 Why?
Chromosomal Instability
1
2013
19
0.030
 Why?
Epitopes
1
2013
84
0.030
 Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
54
0.030
 Why?
Membrane Glycoproteins
2
2006
291
0.030
 Why?
Bone Resorption
1
2015
300
0.030
 Why?
Protein Kinase Inhibitors
1
2014
204
0.030
 Why?
Immunoglobulin M
1
2012
59
0.030
 Why?
Interleukin Receptor Common gamma Subunit
1
2012
10
0.030
 Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
11
0.030
 Why?
Cytomegalovirus
1
2012
28
0.030
 Why?
Adolescent
2
2014
6596
0.030
 Why?
Virus Activation
1
2012
29
0.030
 Why?
Interleukin-2
1
2012
80
0.030
 Why?
Viral Load
1
2012
86
0.030
 Why?
Peripheral Nervous System Diseases
1
2012
60
0.030
 Why?
Immunoenzyme Techniques
1
2012
173
0.030
 Why?
Russell's Viper
1
2011
3
0.030
 Why?
Viper Venoms
1
2011
6
0.030
 Why?
Asymptomatic Diseases
1
2011
41
0.030
 Why?
Osteolysis
1
2012
79
0.030
 Why?
Protein C
1
2011
25
0.030
 Why?
Neoadjuvant Therapy
1
2012
114
0.030
 Why?
Chemotherapy, Adjuvant
1
2011
130
0.030
 Why?
Arkansas
2
2008
2133
0.030
 Why?
Lymphocyte Activation
1
2012
211
0.030
 Why?
Interferon Regulatory Factor-1
1
2010
12
0.030
 Why?
Cell Growth Processes
1
2010
24
0.030
 Why?
CD40 Ligand
1
2010
17
0.030
 Why?
Immunoglobulin Idiotypes
1
2010
18
0.030
 Why?
Hypersensitivity, Delayed
1
2010
21
0.030
 Why?
Interleukin-4
1
2010
48
0.030
 Why?
Antiviral Agents
1
2012
187
0.030
 Why?
Immunity, Cellular
1
2010
82
0.030
 Why?
Adjuvants, Immunologic
1
2010
62
0.030
 Why?
Physician's Role
1
2010
58
0.030
 Why?
Hyperhomocysteinemia
1
2009
32
0.020
 Why?
RNA, Small Interfering
1
2010
267
0.020
 Why?
Education, Medical, Continuing
1
2010
82
0.020
 Why?
Diagnosis, Differential
2
2004
1151
0.020
 Why?
Indazoles
1
2009
49
0.020
 Why?
Cytotoxicity Tests, Immunologic
1
2008
30
0.020
 Why?
Mutation
1
2015
1361
0.020
 Why?
Protein Isoforms
1
2009
134
0.020
 Why?
Vasculitis
1
2008
32
0.020
 Why?
Practice Guidelines as Topic
1
2012
522
0.020
 Why?
Safety
1
2009
98
0.020
 Why?
Ploidies
1
2008
13
0.020
 Why?
Haplotypes
1
2008
101
0.020
 Why?
Algorithms
1
2012
690
0.020
 Why?
Twins
1
2007
33
0.020
 Why?
Double-Blind Method
1
2009
733
0.020
 Why?
Age Distribution
1
2007
193
0.020
 Why?
C-Reactive Protein
1
2008
159
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2007
110
0.020
 Why?
Multigene Family
1
2006
64
0.020
 Why?
Creatinine
1
2007
161
0.020
 Why?
Partial Thromboplastin Time
1
2006
12
0.020
 Why?
Blood Proteins
1
2007
100
0.020
 Why?
Cyclin D
1
2006
21
0.020
 Why?
Syndecans
1
2006
46
0.020
 Why?
Heterozygote
1
2006
84
0.020
 Why?
RNA, Neoplasm
1
2006
58
0.020
 Why?
Cyclins
1
2006
56
0.020
 Why?
HLA-A2 Antigen
1
2005
12
0.020
 Why?
Amiloride
1
2005
12
0.020
 Why?
Proteoglycans
1
2006
96
0.020
 Why?
Transduction, Genetic
1
2005
52
0.020
 Why?
Leukemia, Myeloid, Acute
1
2007
176
0.020
 Why?
Radiography
1
2007
525
0.020
 Why?
Data Interpretation, Statistical
1
2006
177
0.020
 Why?
Interferon-alpha
1
2005
54
0.020
 Why?
Neoplasms, Experimental
1
2006
117
0.020
 Why?
Cell Line
1
2008
1205
0.020
 Why?
Monocytes
1
2005
157
0.020
 Why?
Sensitivity and Specificity
1
2007
953
0.020
 Why?
Databases, Factual
1
2007
677
0.020
 Why?
Clone Cells
1
2004
86
0.020
 Why?
Monosomy
1
2003
5
0.020
 Why?
Antibodies, Monoclonal, Humanized
1
2005
219
0.020
 Why?
Trisomy
1
2003
34
0.020
 Why?
History, 21st Century
1
2003
68
0.020
 Why?
Interphase
1
2003
14
0.020
 Why?
Plasmapheresis
1
2003
14
0.020
 Why?
Fibroblasts
1
2005
376
0.020
 Why?
History, 20th Century
1
2003
126
0.020
 Why?
Back Pain
1
2003
42
0.020
 Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.020
 Why?
Perforin
1
2002
11
0.020
 Why?
Antigen Presentation
1
2002
25
0.020
 Why?
Red-Cell Aplasia, Pure
1
2002
9
0.020
 Why?
United States
1
2013
4825
0.020
 Why?
Anemia
1
2003
92
0.020
 Why?
Cohort Studies
1
2006
1444
0.010
 Why?
Prevalence
1
2005
944
0.010
 Why?
Quality Assurance, Health Care
1
2003
171
0.010
 Why?
Cell Culture Techniques
1
2002
119
0.010
 Why?
DNA, Neoplasm
1
2002
177
0.010
 Why?
Erythrocyte Transfusion
1
2002
86
0.010
 Why?
Graft Rejection
1
2002
158
0.010
 Why?
Kidney Diseases
1
2003
279
0.010
 Why?
Anti-Bacterial Agents
1
2003
756
0.010
 Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (537) concept(s)
_
Co-Authors Expand Description
See all (30) people
_
Similar People Expand Description
See all (26) people
_
Same Department Expand Description
Search Department